DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Bapineuzumab is an investigational drug.
There have been 14 clinical trials for Bapineuzumab. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are Pfizer, JANSSEN Alzheimer Immunotherapy Research & Development, LLC, and Wyeth is now a wholly owned subsidiary of Pfizer.
Recent Clinical Trials for Bapineuzumab
|Retrieval of Patient Information After Discontinuation||Pfizer||N/A|
|Retrieval of Patient Information After Discontinuation||JANSSEN Alzheimer Immunotherapy Research & Development, LLC||N/A|
|Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease||Pfizer||Phase 2|